These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2506166)

  • 1. Mupirocin in a polyethylene glycol carrier base.
    Rode H; de Wet PM; Cywes S; Millar AJ
    J Antimicrob Chemother; 1989 Jul; 24(1):78-9. PubMed ID: 2506166
    [No Abstract]   [Full Text] [Related]  

  • 2. Mupirocin ointment indications.
    Hudson I
    Infect Control Hosp Epidemiol; 1990 Sep; 11(9):452. PubMed ID: 2121821
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical 2% mupirocin versus 2% sodium fusidate ointment in the treatment of primary and secondary skin infections.
    Johnston C
    J Am Acad Dermatol; 1991 May; 24(5 Pt 1):797-8. PubMed ID: 1907980
    [No Abstract]   [Full Text] [Related]  

  • 4. Mupirocin in polyethylene glycol base is not suitable for application to burns.
    Kaczmarski EB
    J Antimicrob Chemother; 1988 Nov; 22(5):771. PubMed ID: 3145270
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of topical mupirocin against an experimental Staphylococcus aureus surgical wound infection.
    Boon RJ; Beale AS; Sutherland R
    J Antimicrob Chemother; 1985 Oct; 16(4):519-26. PubMed ID: 3934130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mupirocin and the eradication of Staphylococcus aureus in atopic dermatitis.
    Luber H; Amornsiripanitch S; Lucky AW
    Arch Dermatol; 1988 Jun; 124(6):853-4. PubMed ID: 3132108
    [No Abstract]   [Full Text] [Related]  

  • 7. Mupirocin ('pseudomonic acid')--a promising new topical antimicrobial agent.
    Casewell MW; Hill RL
    J Antimicrob Chemother; 1987 Jan; 19(1):1-5. PubMed ID: 3104272
    [No Abstract]   [Full Text] [Related]  

  • 8. Impetigo.
    Esterly NB; Nelson DB; Dunne WM
    Am J Dis Child; 1991 Feb; 145(2):125-6. PubMed ID: 1899777
    [No Abstract]   [Full Text] [Related]  

  • 9. Mupirocin--a new topical antibiotic.
    Med Lett Drugs Ther; 1988 May; 30(766):55-6. PubMed ID: 3129636
    [No Abstract]   [Full Text] [Related]  

  • 10. Topical antibiotic treatment of impetigo with mupirocin.
    Eells LD; Mertz PM; Piovanetti Y; Pekoe GM; Eaglstein WH
    Arch Dermatol; 1986 Nov; 122(11):1273-6. PubMed ID: 3096221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections.
    Gilbert M
    J Am Acad Dermatol; 1989 Jun; 20(6):1083-7. PubMed ID: 2502567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical mupirocin vs. systemic erythromycin treatment for pyoderma.
    McLinn S
    Pediatr Infect Dis J; 1988 Nov; 7(11):785-90. PubMed ID: 3148127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mupirocin: a new topical therapy for impetigo.
    Putnam CD; Reynolds MS
    J Pediatr Health Care; 1989; 3(4):224-7. PubMed ID: 2502615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy.
    Mertz PM; Marshall DA; Eaglstein WH; Piovanetti Y; Montalvo J
    Arch Dermatol; 1989 Aug; 125(8):1069-73. PubMed ID: 2502950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of nasal carriage of Staphylococcus aureus with mupirocin ('pseudomonic acid')--a controlled trial.
    Casewell MW; Hill RL
    J Antimicrob Chemother; 1986 Mar; 17(3):365-72. PubMed ID: 3084442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mupirocin (2 percent) ointment in the treatment of primary and secondary skin infections.
    Odom RB
    Cutis; 1989 Jun; 43(6):599-601. PubMed ID: 2501071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical mupirocin in the treatment of bacterial skin infections.
    Rumsfield J; West DP; Aronson IK
    Drug Intell Clin Pharm; 1986 Dec; 20(12):943-8. PubMed ID: 3102197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcus aureus resistant to mupirocin.
    Smith GE; Kennedy CT
    J Antimicrob Chemother; 1988 Jan; 21(1):141-2. PubMed ID: 3128519
    [No Abstract]   [Full Text] [Related]  

  • 19. Innovation and development in oral and topical antibiotics.
    Crook SJ
    Practitioner; 1986 Mar; 230(1413):249-56. PubMed ID: 3086858
    [No Abstract]   [Full Text] [Related]  

  • 20. Mupirocin in the treatment of impetigo. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    CMAJ; 1990 Mar; 142(6):543-4. PubMed ID: 2107019
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.